Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Neuroprostanes [FA0401]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010353 ent-7,14-diepi-14-E4t-NeuroP (Z)-6-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010354 ent-14-epi-14-E4t-NeuroP (Z)-6-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010355 14-epi-14-E4c-NeuroP (Z)-6-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010356 7,14-diepi-14-E4t-NeuroP (Z)-6-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010357 7,14-diepi-14-E4c-NeuroP (Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010358 14-epi-14-E4t-NeuroP (Z)-6-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010359 14-E4c-NeuroP (Z)-6-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010360 7-epi-14-E4t-NeuroP (Z)-6-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010361 7-epi-14-E4c-NeuroP (Z)-6-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010362 14-E4t-NeuroP (Z)-6-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010363 ent-17-E4t-NeuroP (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010364 ent-10-epi-17-E4c-NeuroP (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010365 ent-10-epi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010366 ent-17-E4c-NeuroP (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010367 ent-17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010368 ent-10,17-diepi-17-E4c-NeuroP (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010369 ent-10,17-diepi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010370 ent-17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010371 17-epi-17-E4c-NeuroP (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010372 10,17-diepi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010373 10,17-diepi-17-E4c-NeuroP (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010374 17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010375 17-E4c-NeuroP (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010376 10-epi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010377 10-epi-17-E4c-NeuroP (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010378 17-E4t-NeuroP (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010379 ent-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010380 ent-13-epi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010381 ent-13-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010382 ent-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010383 ent-20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010384 ent-13,20-diepi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010385 ent-13,20-diepi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010386 ent-20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010387 20-epi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010388 13,20-diepi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010389 13,20-diepi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010390 20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010391 20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010392 13-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010393 13-epi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010394 20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid FA 22:6;O3 C22H32O5 376.224975
LMFA04010395 4-epi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010396 ent-7-epi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010397 4,7-diepi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010398 ent-4-A4-NeuroP (R,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010399 4-A4-NeuroP (S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010400 ent-4,7-diepi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010401 7-epi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010402 ent-4-epi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410